Thermo Fisher Scientific (TMO) PT Raised to $610 at Deutsche Bank

Thermo Fisher Scientific (TMO) PT Raised to $615 at Barclays

Barclays analyst Luke Sergott raised the price target on Thermo Fisher Scientific (NYSE: TMO) to $615.00 (from $590.00) while maintaining a Equalweight rating.... More

Midday movers: Tesla, Boeing rise; Uber, Old Dominion Freight fall

(Updated - April 24, 2024 11:14 AM EDT)

Investing.com -- Main U.S. indexes were mixed Wednesday, with tech outperforming other sectors.

Here are some of the biggest U.S. stock movers today:

Tesla (NASDAQ: TSLA) stock soared 12% after the electric vehicle manufacturer said it will move forward the timeline for the release of "more affordable" versions of its cars, gaining despite first-quarter results that were below Wall Street estimates.

AT&T (NYSE: T) stock was flat after the telecoms giant... More

Thermo Fisher lifts profit forecast as medical equipment demand improves

(Reuters) - Thermo Fisher on Wednesday beat Wall Street estimates for quarterly profit and raised its annual profit forecast, betting on improved demand for its products and services used in drug development and sending shares up about 4% premarket.

The medical equipment maker in January signaled that muted demand for its services used in the making of therapies... More

Thermo Fisher Scientific (TMO) lifts guidance after topping Q1 expectations

Thermo Fisher Scientific (NYSE: TMO) shares rose 3.55% after the company reported first-quarter earnings and revenue that exceeded Wall Street's expectations. The company's adjusted earnings per share (EPS) came in at $5.11, surpassing the analyst estimate of $4.71. Revenue for the quarter also beat consensus estimates, reaching $10.34 billion against expectations of $10.16 billion.

The science-serving leader saw a slight decline in revenue compared to the... More

Thermo Fisher Scientific (TMO) Tops Q1 EPS by 40c, raises guidance

Thermo Fisher Scientific (NYSE: TMO) reported Q1 EPS of $5.11, $0.40 better than the analyst estimate of $4.71. Revenue for the quarter came in at $10.34 billion versus the consensus estimate of $10.16 billion.

GUIDANCE:

Thermo Fisher Scientific sees FY2024 EPS of $21.14-$22.02, versus the... More